Scaling cell therapy without scaling the workforce

An overview of how robotic sterile connection may reduce contamination risk, labor dependence and cost per therapy.
  • <<
  • >>

BlueskyReddit

CAR-T capacity is increasingly constrained by people rather than science; eligible patient populations could grow as much as 20-fold, while the skilled workforce needed to serve them takes months to train. This overview examines how robotic sterile connection within a modular, closed system may change that equation... reducing reliance on manual handling, the most frequent source of contamination in fluid transfer. It also outlines what a published cost model reveals about manual versus robotic processing, including where the savings come from and where costs rise.

Access Now

    Please fill out the information below to access the selected content. If you are already registered, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.